FI955755A - Fibrinolyyttisiä ja trombiinia estäviä ominaisuuksia omaavat kimeeriset proteiinit - Google Patents

Fibrinolyyttisiä ja trombiinia estäviä ominaisuuksia omaavat kimeeriset proteiinit Download PDF

Info

Publication number
FI955755A
FI955755A FI955755A FI955755A FI955755A FI 955755 A FI955755 A FI 955755A FI 955755 A FI955755 A FI 955755A FI 955755 A FI955755 A FI 955755A FI 955755 A FI955755 A FI 955755A
Authority
FI
Finland
Prior art keywords
fibrinolytic
chimeric proteins
inhibitory properties
thrombin inhibitory
thrombin
Prior art date
Application number
FI955755A
Other languages
English (en)
Swedish (sv)
Other versions
FI955755A0 (fi
Inventor
Stephan Wnendt
Gerd Josef Steffens
Elke Janocha
Regina Heinzel-Wieland
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of FI955755A0 publication Critical patent/FI955755A0/fi
Publication of FI955755A publication Critical patent/FI955755A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/101—Plasmid DNA for bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI955755A 1994-11-30 1995-11-29 Fibrinolyyttisiä ja trombiinia estäviä ominaisuuksia omaavat kimeeriset proteiinit FI955755A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4442665A DE4442665A1 (de) 1994-11-30 1994-11-30 Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften

Publications (2)

Publication Number Publication Date
FI955755A0 FI955755A0 (fi) 1995-11-29
FI955755A true FI955755A (fi) 1996-05-31

Family

ID=6534566

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955755A FI955755A (fi) 1994-11-30 1995-11-29 Fibrinolyyttisiä ja trombiinia estäviä ominaisuuksia omaavat kimeeriset proteiinit

Country Status (9)

Country Link
US (1) US6133011A (fi)
EP (1) EP0714982A3 (fi)
JP (1) JPH08231595A (fi)
KR (1) KR960017685A (fi)
CA (1) CA2163925A1 (fi)
DE (1) DE4442665A1 (fi)
FI (1) FI955755A (fi)
IL (1) IL116164A0 (fi)
ZA (1) ZA9510154B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4440892A1 (de) * 1994-11-17 1996-05-23 Gruenenthal Gmbh Proteine mit fibrinolytischen und gerinnungshemmenden Eigenschaften
DE19729591A1 (de) * 1997-07-10 1999-02-11 Therasorb Medizinische Systeme Mittel zur Behandlung und/oder Prophylaxe von Mikrozirkulationsstörungen
WO2001094420A1 (en) * 2000-06-05 2001-12-13 The Trustees Of Columbia University In The City Of New York Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
US20030199464A1 (en) 2002-04-23 2003-10-23 Silviu Itescu Regeneration of endogenous myocardial tissue by induction of neovascularization
CN101094867B (zh) 2004-10-19 2011-08-24 隆萨股份公司 用于固相肽合成的方法
JPWO2006082974A1 (ja) * 2005-02-07 2008-06-26 国立大学法人浜松医科大学 虚血性疾患治療剤
CL2011001887A1 (es) 2010-08-05 2012-02-03 Council Scient Ind Res Construcciones de proteinas quimericas que poseen propiedades anticoagulantes y tromboliticas; secuencia de acido nucleico que las codifica; vector; celula huesped; metodo de preparacion; formulacion farmaceutica que las comprende; y su uso para inhibir la trombina.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3823805A1 (de) * 1988-07-14 1990-01-18 Basf Ag Neue polypeptide, ihre herstellung und verwendung
WO1990009438A1 (en) * 1989-02-13 1990-08-23 Schering Aktiengesellschaft Berlin Und Bergkamen Novel thrombolytic
CA1335361C (en) * 1989-05-24 1995-04-25 Andrei Z. Budzynski Thrombus-targeted complexes of plasminogen activator and fibrin fragments
IE901849A1 (en) * 1989-07-19 1991-06-19 Gruenenthal Gmbh Plasmids, their preparation and their use in the manufacture¹of a plasminogen activator
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
US5242810A (en) * 1990-12-07 1993-09-07 Biogen, Inc. Bifunctional inhibitors of thrombin and platelet activation
JPH0578397A (ja) * 1991-01-29 1993-03-30 Sumitomo Pharmaceut Co Ltd 血栓溶解タンパク質
AU1873092A (en) * 1991-04-09 1992-11-17 Brigham And Women's Hospital Chimeric molecule with plasminogen activator activity and affinity for atherosclerotic plaques
DE4323754C1 (de) * 1993-07-15 1994-12-01 Gruenenthal Gmbh Bifunktionelle Urokinasevarianten mit verbesserten fibrinolytischen Eigenschaften und thrombinhemmender Wirkung

Also Published As

Publication number Publication date
JPH08231595A (ja) 1996-09-10
US6133011A (en) 2000-10-17
EP0714982A3 (de) 1999-09-08
FI955755A0 (fi) 1995-11-29
DE4442665A1 (de) 1996-06-05
ZA9510154B (en) 1996-05-06
EP0714982A2 (de) 1996-06-05
CA2163925A1 (en) 1996-05-31
IL116164A0 (en) 1996-01-31
KR960017685A (ko) 1996-06-17

Similar Documents

Publication Publication Date Title
NO20011192L (no) Ranolazinpreparater med depotvirkning
ID23684A (id) Komposisi-polimer-organoclay dan pembuatannya
BR9711799A (pt) Composto de indenonaftopiranos e artigo fotocr-mico
DK0778880T3 (da) Forbedret proteolytisk enzymrensemiddel
FI963185A (fi) Hematopoieettinen proteiini ja materiaalit ja menetelmät sen valmistamiseksi
DE69535031D1 (de) Selektive Acylierung von Epsilon-Aminogruppen in Insulin
NO972625D0 (no) Fibrin-tetningsapplikator
FI972087A (fi) Dihydropyrimidiineja ja niiden käyttöjä
NO971742D0 (no) Sandsil med ökt erosjon- og sammenbruddmotstand
FI971211A0 (fi) Arrangemang i en bergborrmaskin och ett foerfarande foer styrning av bergborrning
BR9506832A (pt) N-pirazolilanilinas e n-pirazolilaminopiridinas
FI960483A (fi) Muunnettava koostumus ja menetelmät sen käyttämiseksi
BR9509641A (pt) Sequências de dna e seu uso
FI955755A (fi) Fibrinolyyttisiä ja trombiinia estäviä ominaisuuksia omaavat kimeeriset proteiinit
FI971376A0 (fi) Trofinin och trofininmedlande proteiner
ATE242270T1 (de) Stabilisierte proteine mit protease- inhibitorfunktion und varianten davon
FI955537A (fi) Fibrinolyyttiset ja hyytymistä estävät proteiinit
FI935559A0 (fi) Foerfarande foer faestning av haordmetallstift i en borrkrona och en borrkrona
DE69522196T2 (de) Pufferschaltung und Vorspannungsschaltung
IT1281294B1 (it) Gioiello e procedimento per la realizzazione dello stesso.
FI944556A0 (fi) Foerfarande foer producering av antracykliner och deras mellanprodukter
DK75794A (da) Fryseapparat samt anvendelse af samme
FI962741A0 (fi) Sollins och braennpunktsvaermare i kombination med vaermeackumulator
FI941501A0 (fi) Kula och foerfarande foer framstaellning av kulor
SE9602287D0 (sv) Novel protein and methods for its use